This inventor holds 2 USPTO granted patents and 3 published patent applications and 6 EPO patents. Top assignees: Dr. Willmar Schwabe Gmbh & Co. Kg, Hg&h Pharmaceuticals (Pty) Ltd. Active years: 2019-2024.
Company Filing History:
Years Active: 2019-2024
Title: Wilfried Dimpfel: Innovator in Pharmaceutical Research
Introduction
Wilfried Dimpfel is a notable inventor based in Wetzlar, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological and sleep disorders. With a total of 2 patents, Dimpfel's work has the potential to impact many lives.
Latest Patents
Dimpfel's latest patents include innovative treatments for epilepsy and sleep disorders. One of his inventions involves the use of mesembranol and mesembrenol, which are alkaloids that serve as pharmaceutical agents for the prophylaxis and treatment of diseases responsive to AMPA receptor antagonists. This invention aims to attenuate AMPA-mediated neurotransmission in the hippocampus, providing a new avenue for treating epilepsy and associated conditions. Additionally, he has developed a combination of valerian root extract and lavender oil for treating sleep disorders, showcasing his commitment to improving patient care through natural remedies.
Career Highlights
Throughout his career, Dimpfel has worked with reputable companies in the pharmaceutical industry. Notable among these are Hg&h Pharmaceuticals and Dr. Willmar Schwabe GmbH & Co. KG. His experience in these organizations has allowed him to refine his research and development skills, leading to his innovative patent filings.
Collaborations
Dimpfel has collaborated with various professionals in his field, including Michael Nöldner. These partnerships have likely contributed to the success of his inventions and the advancement of pharmaceutical research.
Conclusion
Wilfried Dimpfel's contributions to pharmaceutical innovation, particularly in the areas of epilepsy and sleep disorders, highlight his role as a significant inventor. His patents reflect a dedication to improving health outcomes through scientific research and collaboration.